The genes RRM2, KIAA0101, UBE2C, LMX1A, DTL, and LBX1 demonstrated significant overexpression in all human glioma subtypes (GBM, ODG, OA, AA) with a p-value ≤ 0.0001. This evidence concerns the gene LBX1 and central nervous system cancer.